Kimberly A. Arlinghaus, MD
Dr. Arlinghaus is a board-certified general adult psychiatrist with expertise in neuropsychiatry and consult/liaison psychiatry. She is a graduate of the University of Texas at Austin where she earned a Bachelor of Arts in 1982 with highest honor. She then attended Baylor College of Medicine, receiving her medical degree in 1986 with honor. Dr. Arlinghaus completed a general adult psychiatry residency in 1990 at Baylor College of Medicine Affiliated Hospitals Program and received the Laughlin Award for outstanding contributions to the community upon her graduation. She has been a faculty member in the Menninger Department of Psychiatry and Behavioral Sciences and the Department of Physical Medicine and Rehabilitation at Baylor College of Medicine since 1990, achieving the rank of Associate Professor in both departments. In her first five years of practice she founded and directed a neuropsychiatric consultation service at The Institute for Rehabilitation and Research in Houston, Texas where she gained expertise in traumatic brain injury. In 1995, Dr. Arlinghaus moved to the Michael E. DeBakey VA Medical Center in Houston where she contributed 16 years of distinguished service in a variety of leadership, clinical, education, and research positions. In July of 2011 Dr. Arlinghaus embraced a new opportunity to build psychiatry consultation/liaison teaching services in Central Texas within the Lone Star Circle of Care community health system where she now serves as Medical Director of Psychiatry and Behavioral Health as well as Professor of Psychiatry and Behavioral Science at Texas A&M College of Medicine.
Emilie Attwell Becker, M.D.
Dr. Becker has been a practicing physician in Texas since 1982. She has board certifications in child, adolescent, adult and forensic psychiatry. Currently she is the Mental Health Medical Director for Texas Medicaid Chip. In her role, she supervises mental health policy, and consults to the Medicaid Managed Care Organizations and Medicaid Vendor Drug Program. The first Medicaid Behavioral Health Advisory Committee convened under her tutelage. Previously she was the Behavioral Health Medical Director at the Texas Department State Health Services and served as a staff psychiatrist at Austin State Hospital. She has also worked at the Austin local mental health authority, the Texas Youth Commission, managed her own private practice predominantly treating foster children and served as a forensic expert on hundreds of cases. She has co-authored numerous papers, primarily focused on public mental health issues.
James H. Bray, Ph.D.
James H. Bray, Ph.D. was the 2009 President of the American Psychological Association. He is an Associate Professor of Family and Community Medicine at Baylor College of Medicine in Houston, Texas. Dr. Bray’s NIH funded research focuses on adolescent substance use, divorce, remarriage and stepfamilies. He is currently the director of the SAMHSA funded screening, brief intervention and referral to treatment (SBIRT) project for primary care residents at Baylor. He is a pioneer in collaborative healthcare and primary care psychology. He has received numerous awards including election into the National Academies of Practice, elected a fellow of 12 divisions of the APA, and family psychologist of the year in 2008. He also maintains an active clinical practice focusing on children and families. His presidential themes were the Future of Psychology Practice and Science and Psychology’s Contribution to Ending Homelessness.
Thomas M. Brown, M.D.
Author of best-selling book, listed as one of the "250 Best Science Books" in 1998 by Doody's: Psychiatric Side Effects of Prescription and Over-the-Counter Medications. Named one of the top ten federal physician-researchers in 1999 by U.S. Medicine, with nominees coming from the National Institutes of Health, the military, the Veterans Administration, and the Public Health Service. Named one of "San Antonio's Top Doctors" (as referred by peers) for 2008 By Scene in S. A. Current interests include the role of micronutrient deficiencies in causing and aggravation psychiatric illness.
Lingtak-Neander Chan, Pharm.D., BCNSP
Lingtak-Neander Chan, PharmD, BCNSP, is an Associate Professor of Pharmacy and Nutritional Sciences at the University of Washington. He also serves as the clinical specialist for the Bariatric Surgery Program at University of Washington Medical Center. He is a board certified nutrition support pharmacist. His primary area of interest is in the nutritional management of patients in the acute care setting, especially in patients who are critically ill, elderly, obese, or have undergone extensive GI tract surgery. Previously, he was a faculty member of the Colleges of Pharmacy and Medicine at the University of Illinois at Chicago specializing in pulmonary /critical care and nutrition support, where he also served as the co-director of the clinical nutrition team. His current research focuses on the absorption kinetics of micronutrients and drugs after GI tract repair and bariatric surgery. He is currently an associate editor of the Journal of Parenteral and Enteral Nutrition. He is a recipient a number of grants relating to his area of research. In addition to being extensively involved in the pharmacy curriculum, he also mentors graduate students in the Nutritional Sciences Program at the UW School of Public Health and Community Medicine.
April Cope, Pharm.D., BCPP
Dr. April Cope received her Doctorate in Pharmacy from the Arnold and Marie Schwartz College of Pharmacy at Long Island University in 2005. She completed her Pharmacy Practice Residency with Albert Einstein Medical Center in 2007 and went on to complete a 2 year Psychiatric Pharmacy Residency with the University of Texas at Austin and affiliated institutions in 2009. Currently, Dr. Cope is the Clinical Pharmacy Specialist in Behavioral Health at the James E Van Zandt Veteran Affairs Medical Center in Altoona, Pennsylvania. She first became extensively involved with the substance abuse/dependence population during a prior clinical position with the Carl R Darnall Army Medical Center at Fort Hood, Texas where she provided regular education to patients and staff as well as working closely with the department of Psychiatry for regular patient assessments. Dr. Cope’s work with the substance abuse/dependent population has continued with her transition to the VA where she continues to provide education to patients and staff as well as regular assessments of patients to address the complexities of comorbid mental health diagnoses and chemical dependency. She provides additional insight into issues related to mental health and chemical dependency through work with the institution Suboxone treatment team and the multidisciplinary pain committee.
Pedro L. Delgado, MD
After completing Medical School at UTMB, Dr. Delgado completed internship and residency training in psychiatry at Yale University School of Medicine in New Haven, Connecticut in 1987 and served on the Yale faculty until 1992, leading research programs investigating the neurobiological basis of depression and the mechanisms of antidepressant drug action. Over the past 20 years, he has served on the faculty at Yale University School of Medicine, the University of Arizona College of Medicine, and Case Western Reserve School of Medicine. He was Douglas Danford Bond Professor and Chairman of Psychiatry at Case Western Reserve University School of Medicine (2000-2005) and Chairman of the Department of Psychiatry at the UT Health Science Center in San Antonio, Texas from 2005-2013.
His primary research interests have focused on investigation of the neurobiology and treatment of mood and stress disorders, human emotion, and the neurobiological mechanisms of antidepressant action. He has published over 100 scientific articles and book chapters concerning these and related topics, serves on the editorial boards of many prominent psychiatric journals, and is a grant reviewer for the National Institutes of Health. He has a long-standing commitment to research mentoring and clinician scientist training and serves as the director of the UTHSCSA Clinical and Translational Science Award (CTSA) KL2 early career scientist training program.
Larry Ereshefsky, PharmD
Dr. Larry Ereshefsky is Chief Scientific Officer at California Clinical Trials. He is also VP, Principal Clinical Pharmacologist, and Psychiatric Therapeutics Expert for PAREXEL International. Dr. Ereshefsky is an Adjunct Professor of Psychiatry at the University of Texas Health Science Center, San Antonio (UTHSCSA). He is a current and founding member of The International Society for CNS Clinical Trials and Methodology, and is founder of the College of Psychiatric and Neurologic Pharmacy. His academic career spans over 25 years and includes serving as Director of the Psychiatric Pharmacy Program at The University of Texas, Professor of Pharmacology/Psychiatry at the UTHSCSA, Associate Director of Clinical Research at the San Antonio State Hospital, and co-Director of Applied Psychopharmacology and Evaluation Laboratory at UTHSCSA. Dr. Ereshefsky received his Pharm.D., as well as a specialty practice residency in psychiatric pharmacy from the University of Southern California.
Tera D. Moore, Pharm.D., BCPS
Dr. Tera Moore is a graduate of the Doctor of Pharmacy program from the University of New Mexico, College of Pharmacy in 2003. She completed her Primary Care Pharmacy Residency at the South Texas Veterans Health Care System in 2004, then began at the South Texas Veterans Health Care System as a primary care clinical pharmacy specialist. Currently, Dr. Moore serves as the Primary Care Clinical Pharmacy Program Coordinator, lead for the service level pharmacy benefits management, and the Residency Program Director for the ASHP accredited PGY-2 Ambulatory Care Pharmacy Residency. Dr. Moore is a Clinical Assistant Professor with the The University of Texas at Austin College of Pharmacy and Adjoint Assistant Professor, UT Health Science Center San Antonio Pharmacotherapy Education and Research Center.
Dr. Moore's interests include prevention and treatment of chronic medical illness through medication management and lifestyle modifications utilizing motivational interviewing and accelerated learning techniques. Her focus is with vascular risk reduction and optimal management of heart failure to improve quality of life and delay/prevent hospitalizations. Dr. Moore has been on many workgroups related to clinical pharmacy services and outcomes. She has completed outcomes research related to clinical pharmacy interventions provided in the primary care setting, evaluated outcomes for the Vascular Risk Reduction and Diabetes Interdisciplinary Workshop, and most recently understanding barriers to healthcare based on the attitudes of patients towards healthcare providers in the primary care setting.
Troy A. Moore, Pharm.D., M.S., BCPP
Troy A. Moore received his PharmD from the University of New Mexico College of Pharmacy in 2003. He subsequently attended the University of Texas at Austin College, receiving his Master of Science in Pharmacy in 2005 while completing a 2 year Psychiatric Pharmacy at the San Antonio State Hospital and the South Texas Veterans Health Care System (STVHCS). He joined the University of Texas Health Science Center at San Antonio Department of Psychiatry, Division of Schizophrenia and Related Disorders in 2005 and became Assistant Professor in 2007. He joined the STVHCS as Clinical Pharmacy Specialist in Psychiatry in 2010 where he serves the Substance Abuse and Domiciliary Programs. He is the author of numerous publications, including the Texas Medication Algorithm Project antipsychotic algorithm for schizophrenia: 2006 update. He is a reviewer for multiple psychiatric and pharmacy journals. He is currently is the Director of the ASHP accredited PGY-2 Psychiatric Pharmacy Residency at STVHCS, serves as the Member-at-Large on the Board of Director for the College of Psychiatric and Neurologic, and serves as a member of the Board of Pharmacy Specialties Specialty Council on Psychiatric Pharmacy.
Stephen R. Saklad, Pharm.D., BCPP
Dr Saklad joined the faculty of The University of Texas College of Pharmacy and the staff of San Antonio State Hospital in 1979. He has focused on providing the excellent teaching and pharmaceutical care to improve the quality of life and function in the serious and persistently mentally ill. He wrote and successfully lobbied for the creation of a clinical research unit at San Antonio State Hospital funded by the Texas Legislature and governed by the College of Pharmacy, Department of Psychiatry and San Antonio State Hospital. He developed the first websites for The University of Texas College of Pharmacy in 1994 and the College of Psychiatric and Neurologic Pharmacists (CPNP) in 1997. He is Director of the University of Texas Psychiatric Pharmacy Program in San Antonio, Founding Member of CPNP, served on the CPNP Board of Directors, and was the founding senior editor of their journal, the Mental Health Clinician. He has served as the clinical chair of The University of Texas Psychiatric Pharmacotherapy Update since 2005. He has published articles and presented to many groups around the country on a variety of pharmacy and mental health related topics. He is a principal or co-investigator for several studies of the efficacy and adverse effects of Phase II, III, and IV psychotropic agents in schizophrenia, mood disorders, and other serious mental illnesses, as well as their pharmacokinetics and interactions. He has received several honors, most recently the Judith J. Saklad Memorial Award from CPNP in 2012 and Teaching Excellence Award from the UT College of Pharmacy in 2013.
Jana Shults, Pharm.D., BCPP
Dr. Jana G. Shults received her Doctorate of Pharmacy from the University of Oklahoma College of Pharmacy in 2009. She completed her PGY-1 Pharmacy Residency at the Oklahoma City Veterans Affairs Medical Center, and subsequently completed her PGY-2 Psychiatric Pharmacy Residency at the Central Texas Veterans Health Care System in 2011. Dr. Shults joined the South Texas Veterans Health Care System (STVHCS) as Clinical Pharmacy Specialist in Psychiatry in 2012 where she works with Mental Health Outpatient Services. She co-manages a specialty clinic at STVHCS geared toward meeting the needs of veterans coping with bipolar disorder.
Tawny L. Smith, Pharm.D., BCPP
Dr. Tawny Smith attended the University of Illinois-Chicago where she received her doctorate of pharmacy degree. She completed her psychiatric pharmacy residency training at The University of Texas at Austin and the Austin State Hospital. Following that, she completed a fellowship in Clinical Psychiatric Pharmacy at The University of Texas at Austin.
Dr. Smith is a board-certified psychiatric pharmacist serving as an Assistant Professor in the Department of Psychiatry at UT Southwestern Medical Center at Austin. She is also the director of the The University of Texas at Austin post-graduate year 2 psychiatric pharmacy residency. Dr. Smith currently practices at Seton Shoal Creek Hospital and the Seton Mind Institute. She has over 40 published abstracts, peer reviewed articles and book chapters in the area of psychiatric pharmacy. Dr. Smith has also served as principal investigator and co-investigator on several research projects.
Roger W. Sommi, Pharm.D., FCCP, BCPP
Dr. Sommi is Professor at the UMKC School of Pharmacy - Department of Pharmacy Practice, with a cross appointment in the Department of Psychiatry. He is also Research Director at the Psychopharmacy Research and Education Program at the Center for Behavioral Medicine (formerly Western Missouri Mental Health Center). He received his BS in Pharmacy from the University of Wisconsin at Madison, Doctor of Pharmacy the University of Utah, Residency in Hospital Pharmacy at the University of Utah Hospital and Fellowship in Psychopharmacy at the University of Texas at Austin. He is board certified in Psychiatric Pharmacy Practice by the Board of Pharmaceutical Specialties, Fellow of the American College of Clinical Pharmacy and is past president of the College of Psychiatric and Neurologic Pharmacists.
Dr. Sommi's area of research interest is primarily in outcomes associated with drug treatment of schizophrenia and other psychiatric disorders. His practice is primarily associated with the ongoing projects in the research program. He is also a consultant with several community mental health centers. He is also involved with the local Kansas City NAMI as an instructor in the Crisis Intervention Team training program for local law enforcement agencies.
Madhukar Trivedi, M.D.
Madhukar H. Trivedi, M.D. is Professor of Psychiatry, Chief of the Division of Mood Disorders, and Director of the Comprehensive Center for Depression at the University of Southwestern of Texas Medical Center. He holds the Betty Joe Hay Distinguished Chair in Mental Health. Dr. Trivedi is an established efficacy and translation researcher in Mood Disorders. Dr. Trivedi has focused his research on the neurobiology of depression as well as pharmacological, psychosocial, and other non-pharmacological treatments for depression.
Dr. Trivedi has been a principal investigator in multiple clinical trails funded through NIMH and the Texas Department of Mental Health. He is the Principal Investigator of the NIDA-funded Clinical Trails Network. He was the PI of the depression Trials Network “combining Medication to Enhance Depression Outcomes (CO-MED)” trail, as well as co-PI of the NIMH funded project entitled “Sequenced Treatment Alternatives to Relieve Depression.” He was recently selected to be the Lead PI for the team conducting the EMBARC project, the core goal to identify a bio-signature for depression. Dr. Trivedi has been involved with the National Network of Depression Centers (NNDC), including leading the effort to formulate the Comprehensive Assessment Package being used in the NNDC. He currently serves as Co-Chair of the Biomarker Task Group.
Dr. Trivedi has received numerous awards including the Gerald L. Klerman award from the National Depressive and Mani-Depressive Association Scientific Advisory Board-NDMDA and the Psychiatric Excellence Award from the Texas Society of Psychiatric Physicians – TSPP. He has published over 420 articles and chapters related to the Diagnosis and Treatment of Mood Disorders.
|The University of Texas at Austin College of Pharmacy is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.|
|Comments to: UTPharmacyCE@austin.utexas.edu
Download free PDF Reader | Download free MS Reader
©2012 College of Pharmacy, The University of Texas at Austin